Breaking News

AdvantaPure’s AdvantaPass Assigned Patent

System ensures room isolation during fluid transfer

By: Kristin Brooks

Managing Editor, Contract Pharma

AdvantaPure has been assigned U.S. patent for AdvantaPass wall pass-through technology. Introduced earlier this year, AdvantaPass is used to transfer large volumes of fluids between clean rooms during pharma and biopharma production. The system maintains the separation of room atmospheres and is designed to minimize cross contamination risks.

AdvantaPass combines single-use tubing, connectors and seals with permanent, wall-mounted stainless steel components to eliminate cleaning validations, and is the first system of its kind to provide complete isolation between manufacturing suites when conveying multiple lines of fluid through a single wall portal, according to the company.

The patent is associated with the single portal for more than one transfer, as other systems are not designed to manage more than one line per wall portal without breaking protocol and risking room or product contamination.

“Combining the durability and dependability of stainless steel parts with the purity, ease of use and cost-effectiveness of Single-Use components offers several advantages,” said Tony Butler, manager of Single-Use Applications for AdvantaPure. “AdvantaPass involves fewer moving parts and less maintenance than similar systems, and it’s easy to assemble and disassemble. It’s customizable and can be used with new construction or retrofitted.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters